SARAHREAGAN HUGHES: Open Payments
NPI 1235722380 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,138 in 59 payments from 11 companies in 2025. Trend: 2023 $582 · 2024 $712 · 2025 $1,138
Food & beverage: $1,138
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $226 |
| ABBVIE INC. | 10 | $200 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $199 |
| Galderma Laboratories, L.P. | 10 | $144 |
| Novartis Pharmaceuticals Corporation | 5 | $122 |
| GENZYME CORPORATION | 2 | $68 |
| Lilly USA, LLC | 4 | $59 |
| UCB, Inc. | 2 | $50 |
| Organon LLC | 1 | $30 |
| Incyte Corporation | 1 | $26 |
Products named: TREMFYA, ILUMYA, NEMLUVIO, COSENTYX, SKYRIZI, RINVOQ, DUPIXENT, EBGLYSS.
Industry payments across AL — which companies pay providers there.
